Immunotherapy for Merkel cell carcinoma — novel research highlights quality of life benefits – EurekAlert (press release)
|
Immunotherapy for Merkel cell carcinoma — novel research highlights quality of life benefits
EurekAlert (press release) Future Science Group (FSG) today announced the publication of an article in Future Oncology that has demonstrated in patients with metastatic Merkel cell carcinoma (mMCC), non-progression during treatment with the anti-PD-L1 immunotherapy avelumab … |
